T-cell epitope vaccine design by immunoinformatics
暂无分享,去创建一个
[1] Taku Suto,et al. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries , 2000, Immunogenetics.
[2] E. Pålsson-McDermott,et al. Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4 , 2004, Immunology.
[3] Shoba Ranganathan,et al. Modeling the structure of bound peptide ligands to major histocompatibility complex , 2004, Protein science : a publication of the Protein Society.
[4] P. Petrone,et al. MHC-peptide binding is assisted by bound water molecules. , 2004, Journal of molecular biology.
[5] L. Baum,et al. A Maximization Technique Occurring in the Statistical Analysis of Probabilistic Functions of Markov Chains , 1970 .
[6] Qi Liu,et al. A HMM-based method to predict the transmembrane regions of \beta-barrel membrane proteins , 2003, Comput. Biol. Chem..
[7] A Sette,et al. A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets. , 1997, Human immunology.
[8] M. Mahler,et al. Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. , 2003, Clinical immunology.
[9] Pingping Guan,et al. EpiJen: a server for multistep T cell epitope prediction , 2006, BMC Bioinformatics.
[10] P. Coveney,et al. Molecular Basis of Peptide Recognition by the TCR: Affinity Differences Calculated Using Large Scale Computing1 , 2005, The Journal of Immunology.
[11] Biing-Hwang Juang,et al. Hidden Markov Models for Speech Recognition , 1991 .
[12] J. Fagerberg,et al. T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma. , 2003, Blood.
[13] C. Del Carpio,et al. A combined bioinformatic approach oriented to the analysis and design of peptides with high affinity to MHC class I molecules , 2002, Immunology and cell biology.
[14] P. Butler,et al. Assembly of a spherical plant virus. , 1976, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[15] J. Drijfhout,et al. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. , 1995, Human immunology.
[16] Søren Buus,et al. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding , 1996, European journal of immunology.
[17] E. Celis,et al. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. , 2000, Cancer research.
[18] W. Szmuness,et al. The immune response of healthy adults to a reduced dose of hepatitis B vaccine , 1981, Journal of medical virology.
[19] Irini Doytchinova,et al. The HLA-A2-supermotif: a QSAR definition. , 2003, Organic & biomolecular chemistry.
[20] Hiroyuki Honda,et al. Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma , 2004, BMC Bioinformatics.
[21] B. Walker,et al. HIV versus the immune system: another apparent victory for the virus. , 2001, The Journal of clinical investigation.
[22] Didier Rognan,et al. Recovery of known T-cell epitopes by computational scanning of a viral genome , 2002, J. Comput. Aided Mol. Des..
[23] J. Pipas,et al. Chaperone-mediated in vitro assembly of Polyomavirus capsids , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Alex Bateman,et al. HMM-based databases in InterPro , 2002, Briefings Bioinform..
[25] D. Wiley,et al. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] R W Chesnut,et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.
[27] Jian Huang,et al. CED: a conformational epitope database , 2006, BMC Immunology.
[28] K. Asadpour‐Zeynali,et al. Modeling drug solubility in water-cosolvent mixtures using an artificial neural network. , 2004, Farmaco.
[29] Miles P. Davenport,et al. An empirical method for the prediction of T-cell epitopes , 2004, Immunogenetics.
[30] N. Petrovsky,et al. Immunoinformatics and its relevance to understanding human immune disease , 2005, Expert review of clinical immunology.
[31] Manoj Bhasin,et al. Analysis and prediction of affinity of TAP binding peptides using cascade SVM , 2004, Protein science : a publication of the Protein Society.
[32] Atsushi Imiya,et al. Machine Learning and Data Mining in Pattern Recognition , 2013, Lecture Notes in Computer Science.
[33] U. Şahin,et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.
[34] R. Meloen,et al. Synthetic peptide vaccines: unexpected fulfillment of discarded hope? , 2001, Biologicals : journal of the International Association of Biological Standardization.
[35] Richard G. Jenner,et al. Viral bioinformatics: computational views of host and pathogen. , 2003, Novartis Foundation symposium.
[36] Nebojsa Jojic,et al. Efficient approximations for learning phylogenetic HMM models from data , 2004, ISMB/ECCB.
[37] C. Jacob,et al. Priming immunization against cholera toxin and E. coli heat‐labile toxin by a cholera toxin short peptide‐beta‐galactosidase hybrid synthesized in E. coli. , 1985, The EMBO journal.
[38] D. Rognan,et al. Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein. , 1995, Acta crystallographica. Section D, Biological crystallography.
[39] Chee Keong Kwoh,et al. PREDTAP: a system for prediction of peptide binding to the human transporter associated with antigen processing , 2006, Immunome research.
[40] Channa K. Hattotuwagama,et al. Integrating In Silico and In Vitro Analysis of Peptide Binding Affinity to HLA-Cw*0102: A Bioinformatic Approach to the Prediction of New Epitopes , 2009, PloS one.
[41] Ruben Abagyan,et al. Prediction of the binding energy for small molecules, peptides and proteins , 1999, Journal of molecular recognition : JMR.
[42] Victor Ciesielski,et al. Application of Genetic Search in Derivation of Matrix Models of Peptide Binding to MHC Molecules , 1997, ISMB.
[43] W. W. Nichols,et al. Plasmid DNA Vaccines: Tissue Distribution and Effects of DNA Sequence, Adjuvants and Delivery Method on Integration into Host DNA , 2001, Intervirology.
[44] Naoki Abe,et al. Prediction of MHC Class I Binding Peptides by a Query Learning Algorithm Based on Hidden Markov Models , 2002, Journal of biological physics.
[45] C. Bridges,et al. Seasonal influenza vaccines. , 2009, Current topics in microbiology and immunology.
[46] K. Timmis,et al. Oral Somatic Transgene Vaccination Using Attenuated S. typhimurium , 1997, Cell.
[47] C A Floudas,et al. A predictive method for the evaluation of peptide binding in pocket 1 of HLA‐DRB1 via global minimization of energy interactions , 1997, Proteins.
[48] S. Smith. The polyepitope approach to DNA vaccination. , 1999, Current opinion in molecular therapeutics.
[49] D. Rognan,et al. Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. , 1999, Journal of medicinal chemistry.
[50] Z. Nagy,et al. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.
[51] Pierre Baldi,et al. COBEpro: a novel system for predicting continuous B-cell epitopes. , 2009, Protein engineering, design & selection : PEDS.
[52] Irini A. Doytchinova,et al. EpiTOP - a proteochemometric tool for MHC class II binding prediction , 2010, Bioinform..
[53] P. Travers,et al. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. , 1998, Journal of immunology.
[54] J. Rothbard,et al. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. , 1994, Journal of immunology.
[55] Stefan Kienle,et al. Tolerance to Amino Acid Variations in Peptides Binding to the Major Histocompatibility Complex Class I Protein H-2Kb(*) , 1995, The Journal of Biological Chemistry.
[56] O. Schueler‐Furman,et al. Structure‐based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles , 2000, Protein science : a publication of the Protein Society.
[57] D Rognan,et al. Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes. , 1994, Biochemistry.
[58] C. Montesano,et al. Computer-Based Design of an HLA-Haplotype and HIV-Clade Independent Cytotoxic T-Lymphocyte (CTL) Assay for Monitoring HIV-Specific Immunity , 2002, Molecular medicine.
[59] O. Lund,et al. An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions , 2005, European journal of immunology.
[60] M. Delorenzi,et al. An HMM model for coiled-coil domains and a comparison with PSSM-based predictions , 2002, Bioinform..
[61] W. W. Nichols,et al. Plasmid DNA vaccines: assay for integration into host genomic DNA. , 2000, Developments in biologicals.
[62] Darren R Flower,et al. Coupling In Silico and In Vitro Analysis of Peptide-MHC Binding: A Bioinformatic Approach Enabling Prediction of Superbinding Peptides and Anchorless Epitopes , 2004, The Journal of Immunology.
[63] H. Margalit,et al. Insights from MHC-bound peptides. , 2003, Novartis Foundation symposium.
[64] Matteo Bellone,et al. Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11 , 1999, The Journal of experimental medicine.
[65] E. Pamer,et al. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes , 1991, Nature.
[66] L Raddrizzani,et al. In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program1 , 2000, The Journal of Immunology.
[67] Meena Kishore Sakharkar,et al. Types of inter-atomic interactions at the MHC-peptide interface: Identifying commonality from accumulated data , 2002, BMC Structural Biology.
[68] T. Lundstedt,et al. Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. , 2001, Biochimica et biophysica acta.
[69] Claude Beazley,et al. A Novel Predictive Technique for the MHC Class II Peptide-Binding Interaction , 2003, Molecular medicine.
[70] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .
[71] Irini A. Doytchinova,et al. Towards the chemometric dissection of peptide – HLA-A*0201 binding affinity: comparison of local and global QSAR models , 2005, J. Comput. Aided Mol. Des..
[72] S. Tenzer,et al. Using the World Wide Web for predicting CTL epitopes. , 2003, Current opinion in immunology.
[73] H. Rammensee,et al. Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2. , 2003, Cancer immunity.
[74] Gajendra P. S. Raghava,et al. ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..
[75] Vladimir Brusic,et al. Prediction of promiscuous peptides that bind HLA class I molecules , 2002, Immunology and cell biology.
[76] A. Sette,et al. T-lymphocyte epitope identification and their use in vaccine development for HIV-1. , 2002, Frontiers in bioscience : a journal and virtual library.
[77] Lawrence R. Rabiner,et al. A tutorial on hidden Markov models and selected applications in speech recognition , 1989, Proc. IEEE.
[78] M. Cheever,et al. Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[79] I. Hellstrom,et al. Novel approaches to therapeutic cancer vaccines , 2003, Expert review of vaccines.
[80] S. Vajda,et al. Protein-protein docking: is the glass half-full or half-empty? , 2004, Trends in biotechnology.
[81] P. Mortimer. Can postexposure vaccination against smallpox succeed? , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[82] Yingdong Zhao,et al. T-Cell Epitope Prediction with Combinatorial Peptide Libraries , 2003, J. Comput. Biol..
[83] H. Rammensee,et al. Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes , 2004, Cancer Immunology, Immunotherapy.
[84] Fang-Xiang Wu,et al. Optimally-connected Hidden Markov Models for Predicting Mhc-binding Peptides , 2006, J. Bioinform. Comput. Biol..
[85] M. Bishop,et al. Maximum likelihood alignment of DNA sequences. , 1986, Journal of molecular biology.
[86] Morten Nielsen,et al. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 , 2008, Nucleic Acids Res..
[87] Thomas Jackson,et al. Neural Computing - An Introduction , 1990 .
[88] H. Rammensee,et al. The making of the dominant MHC class I ligand SYFPEITHI , 1998, European journal of immunology.
[89] A. Alix,et al. Predictive estimation of protein linear epitopes by using the program PEOPLE. , 1999, Vaccine.
[90] Rajat K De,et al. Immunoinformatics: an integrated scenario , 2010, Immunology.
[91] Jun Zeng,et al. Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach , 2001, J. Comput. Aided Mol. Des..
[92] A. D. De Groot,et al. Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. , 1998, Vaccine.
[93] Wen Liu,et al. Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models , 2006, BMC Bioinformatics.
[94] Michael A. Gonzalez,et al. From genome to vaccine: in silico predictions, ex vivo verification. , 2001, Vaccine.
[95] Ulrike Alexiev,et al. Differential Peptide Dynamics Is Linked to Major Histocompatibility Complex Polymorphism* , 2004, Journal of Biological Chemistry.
[96] J. Fagerberg,et al. Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA , 2004, Cancer Immunology, Immunotherapy.
[97] Pingping Guan,et al. MHCPred: a server for quantitative prediction of peptide-MHC binding , 2003, Nucleic Acids Res..
[98] James Robinson,et al. The IMGT/HLA database , 2008, Nucleic Acids Res..
[99] Eugene I Shakhnovich,et al. Structural mining: self-consistent design on flexible protein-peptide docking and transferable binding affinity potential. , 2004, Journal of the American Chemical Society.
[100] Søren Brunak,et al. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach , 2004, Bioinform..
[101] S Vajda,et al. Toward computational determination of peptide‐receptor structure , 1993, Protein science : a publication of the Protein Society.
[102] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[103] A. Suhrbier,et al. Prediction of an HLA B8-restricted influenza epitope by motif. , 1993, Immunology.
[104] Thorsten Joachims,et al. Making large-scale support vector machine learning practical , 1999 .
[105] B. Schölkopf,et al. Advances in kernel methods: support vector learning , 1999 .
[106] Ettore Appella,et al. A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. , 2003, Immunity.
[107] Theodore V. Tselios,et al. NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations. , 2004, European journal of biochemistry.
[108] H. Margalit,et al. Sequence features that correlate with MHC restriction. , 1994, Molecular immunology.
[109] J. Berzofsky,et al. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. , 1995, Vaccine.
[110] Ali Azizi,et al. Innovative bioinformatic approaches for developing peptide‐based vaccines against hypervariable viruses , 2011, Immunology and cell biology.
[111] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques with Java implementations , 2002, SGMD.
[112] Stuart Berman,et al. Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[113] H. Volk,et al. Random Screening of Proteins for HLA-A*0201-Binding Nine-Amino Acid Peptides Is Not Sufficient for Identifying CD8 T Cell Epitopes Recognized in the Context of HLA-A*02011 , 2004, The Journal of Immunology.
[114] Loris Nanni,et al. Machine learning algorithms for T-cell epitopes prediction , 2006, Neurocomputing.
[115] Mark M. Davis,et al. Two-step binding mechanism for T-cell receptor recognition of peptide–MHC , 2002, Nature.
[116] Clemencia Pinilla,et al. A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. , 2004, Molecular immunology.
[117] E. Reinherz,et al. Prediction of MHC class I binding peptides using profile motifs. , 2002, Human immunology.
[118] Robert H Levis,et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[119] N. Brewer,et al. Evaluating the impact of human papillomavirus vaccines. , 2009, Vaccine.
[120] A Sette,et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.
[121] Simon Cawley,et al. HMM sampling and applications to gene finding and alternative splicing , 2003, ECCB.
[122] H. Sbai,et al. Use of T cell epitopes for vaccine development. , 2001, Current drug targets. Infectious disorders.
[123] P. Kloetzel,et al. MAPPP: MHC class I antigenic peptide processing prediction. , 2003, Applied bioinformatics.
[124] Olivier Michielin,et al. Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis. , 2002, Journal of molecular biology.
[125] H. Kalbacher,et al. New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library. , 1996, European journal of biochemistry.
[126] Piero Fariselli,et al. A sequence-profile-based HMM for predicting and discriminating beta barrel membrane proteins , 2002, ISMB.
[127] S. Muta,et al. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217. , 2000, Biopolymers.
[128] H Mamitsuka,et al. Predicting peptides that bind to MHC molecules using supervised learning of hidden markov models , 1998, Proteins.
[129] S Vajda,et al. Flexible docking of peptides to class I major-histocompatibility-complex receptors. , 1995, Genetic analysis : biomolecular engineering.
[130] P. Stern,et al. Vaccine and antibody-directed T cell tumour immunotherapy. , 2004, Biochimica et biophysica acta.
[131] M. Colombo,et al. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. , 1998, Blood.
[132] R. Sundaram,et al. Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1. , 2008, The journal of peptide research : official journal of the American Peptide Society.
[133] Chris H. Q. Ding,et al. Multi-class protein fold recognition using support vector machines and neural networks , 2001, Bioinform..
[134] H. Grey,et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[135] A. Tarkowska,et al. Prediction of left ventricular ejection fraction in patients with coronary artery disease based on an analysis of perfusion patterns at rest. Assessment by an artificial neural network. , 2004, Nuclear medicine review. Central & Eastern Europe.
[136] Limsoon Wong,et al. FIMM, a database of functional molecular immunology , 2000, Nucleic Acids Res..
[137] D. Haussler,et al. Hidden Markov models in computational biology. Applications to protein modeling. , 1993, Journal of molecular biology.
[138] Richard A. Goldstein,et al. Performance of an iterated T-HMM for homology detection , 2004, Bioinform..
[139] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[140] K. Kim,et al. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling. , 1996, Molecular immunology.
[141] Steven Salzberg,et al. A Weighted Nearest Neighbor Algorithm for Learning with Symbolic Features , 2004, Machine Learning.
[142] G. Jung,et al. From combinatorial libraries to MHC ligand motifs, T-cell superagonists and antagonists. , 2001, Biologicals : journal of the International Association of Biological Standardization.
[143] Irini A. Doytchinova,et al. BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .
[144] M. Tommasino,et al. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. , 2003, Human immunology.
[145] I. Haworth,et al. Water dynamics at the binding interface of four different HLA-A2-peptide complexes. , 2000, International immunology.
[146] T. Lehner,et al. Identification of T- and B-cell epitopes in synthetic peptides derived from a Streptococcus mutans protein and characterization of their antigenicity and immunogenicity. , 1990, Archives of oral biology.
[147] R. Naz,et al. Peptide vaccines against cancer, infectious diseases, and conception. , 2007, Frontiers in bioscience : a journal and virtual library.
[148] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[149] C. DeLisi,et al. Free energy mapping of class I MHC molecules and structural determination of bound peptides , 1996, Protein science : a publication of the Protein Society.
[150] P. Pastoret,et al. A brief history of vaccines and vaccination. , 2007, Revue scientifique et technique.
[151] S. Nathenson,et al. Methods to study peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.
[152] Zhong Huang,et al. Virus-like particles production in green plants. , 2006, Methods.
[153] D. Klinman,et al. DNA vaccines: safety and efficacy issues , 2004, Springer Seminars in Immunopathology.
[154] S. Gurunathan,et al. DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.
[155] Gajendra P. S. Raghava,et al. Pcleavage: an SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences , 2005, Nucleic Acids Res..
[156] B. Baker,et al. Thermodynamic and kinetic analysis of a peptide-class I MHC interaction highlights the noncovalent nature and conformational dynamics of the class I heterotrimer. , 2003, Biochemistry.
[157] T. Liesegang. Varicella zoster virus vaccines: effective, but concerns linger. , 2009, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[158] L. Moreland. MHC class II molecules , 2004 .
[159] T. Hanai,et al. Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. , 2002, Journal of bioscience and bioengineering.
[160] P. Barker,et al. Efficient Generation of Major Histocompatibility Complex Class I-Peptide Complexes Using Synthetic Peptide Libraries* , 1998, The Journal of Biological Chemistry.
[161] T. Elliott,et al. Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. , 2000, Tissue antigens.
[162] M H Lessof,et al. Advances in immunology. , 1978, The Practitioner.
[163] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[164] R Elber,et al. Knowledge-based structure prediction of MHC class I bound peptides: a study of 23 complexes. , 1998, Folding & design.
[165] J L Cornette,et al. Consistency in structural energetics of protein folding and peptide recognition , 1997, Protein science : a publication of the Protein Society.
[166] Rajeev K. Azad,et al. Probabilistic methods of identifying genes in prokaryotic genomes: Connections to the HMM theory , 2004, Briefings Bioinform..
[167] S. Higgs,et al. A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection , 2010, Nature Medicine.
[168] D R Flower,et al. MHC Class II Binding Prediction by Molecular Docking , 2011, Molecular informatics.
[169] H. L. Hiew,et al. MHC haplotype analysis by artificial neural networks. , 1998, Human immunology.
[170] Ji Wan,et al. SVRMHC prediction server for MHC-binding peptides , 2006, BMC Bioinformatics.
[171] W. Szmuness,et al. PASSIVE.ACTIVE IMMUNISATION AGAINST HEPATITIS B: IMMUNOGENICITY STUDIES IN ADULT AMERICANS , 1981, The Lancet.
[172] Vladimir Vapnik,et al. Statistical learning theory , 1998 .
[173] B Honig,et al. On the calculation of binding free energies using continuum methods: Application to MHC class I protein‐peptide interactions , 1997, Protein science : a publication of the Protein Society.
[174] Sean R. Eddy,et al. Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids , 1998 .
[175] M. Bayer,et al. Particles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and Hepatitis , 1968, Nature.
[176] D. Rognan,et al. Customized versus universal scoring functions: application to class I MHC-peptide binding free energy predictions. , 2001, Bioorganic & medicinal chemistry letters.
[177] M. A. Liu,et al. DNA vaccines: a review , 2003, Journal of internal medicine.
[178] W. Hahn,et al. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. , 1999, Immunity.